AQR Capital Management
PRCT icon

AQR Capital Management’s Procept Biorobotics PRCT Stock Holding History

AQR Capital Management’s Portfolio PRCT Stock Details PRCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$6.4M Buy
255,851
+212,793
+494% +$6M ﹤0.01% 1589
2025
Q4 		$1.35M Sell
43,058
-23,283
-35% -$772K ﹤0.01% 2374
2025
Q3 		$2.37M Buy
66,341
+12,887
+24% +$588K ﹤0.01% 1882
2025
Q2 		$3.08M Buy
53,454
+34,562
+183% +$1.95M ﹤0.01% 1541
2025
Q1 		$1.1M Buy
18,892
+1,286
+7% +$87.8K ﹤0.01% 1965
2024
Q4 		$1.42M Buy
17,606
+8,590
+95% +$734K ﹤0.01% 1703
2024
Q3 		$722K Buy
9,016
+3,877
+75% +$275K ﹤0.01% 2008
2024
Q2 		$314K Buy
+5,139
New +$306K ﹤0.01% 2248

Other funds holding PRCT

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
CC
Chicago Capital Chicago, Illinois $3.71B AUM 19.51% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return